Houston-based VoltaGrid provides small-scale, self-contained microgrids that can operate independently of major power grids or in tandem with other microgrids. Photo via voltagrid.com

VoltaGrid, a Bellaire-based startup that specializes in distributed power generation via microgrids, has hauled in $150 million in equity funding.

Founded in 2020, VoltaGrid provides small-scale, self-contained microgrids that can operate independently of major power grids or in tandem with other microgrids. VoltaGrid’s product consists of natural gas engines, portable energy storage, natural gas processing and grid power connectivity.

Investors in the $150 million round include the Canada Pension Plan Investment Board (CPP Investments), Longbow Capital, Walter Ventures, and Pilot Company (operator of more than 800 retail and fueling locations in the U.S. and Canada). The $150 million round comes less than a year after VoltaGrid announced a $100 million round featuring the same investors.

VoltaGrid says it will spend the fresh cash to grow its power generation portfolio, along with its low-carbon fuel program in partnership with Pilot. The low-carbon platform features hydrogen and compressed natural gas.

“VoltaGrid continues to set new milestones across multiple sectors and business lines as we execute on our proven strategy with key partners,” Nathan Ough, president and CEO of VoltaGrid, says in a news release.

“Our strategy to establish one of the largest asset bases of portable generation, uniquely paired with our low-carbon fueling solutions, has significantly decreased the complexity for our partners to electrify their operations. I am thankful to our team members for the tremendous amount of work that has been contributed to create one of the largest portfolios of contracted low carbon fuels in the industry.”

Ed Pettitt and Paresh Patel join the Houston Innovators Podcast to discuss InnoGrid's potential impact on equitable power. Photos courtesy of InnoGrid

Houston founders aim to provide equity through energy resiliency

Houston innovators podcast episode 143

As temperatures climb and devastating natural disasters continue to test the power grid, two Houston innovators have a solution: Smart microgrids.

"Microgrids have been around for a very long time," Paresh Patel, co-founder of InnoGrid, says on the Houston Innovators Podcast. "We're primed here in Houston and in Texas to really see microgrids go mainstream. ... People want to see that they have control and are in charge of their own power."

Patel co-founded InnoGrid with Ed Pettitt and a few other collaborators following the 2020 Houston Climathon. The social enterprise is working to establish community microgrids in lower income areas — neighborhoods that are most at risk of devastating power outages.

"We want to convert the commercial microgrid model for low and moderate income and undresourced residential communities," Patel explains.

And there's never been a better time to shine a spotlight on microgrids as a solution to unreliable power systems, Pettitt says.

"We're dealing with massive inflation — costs are going up especially in food and energy," he explains on the show. "Even prior to this time of inflation, electricity prices in the US were expected to increase across the board. Hundreds of thousands of people right now today are being pushed below the poverty line because of increased energy costs. We need to be more creative in how we upgrade our infrastructure."

And the current grid system is well overdue for an upgrade. The microgrid system fits right in with the shared economy we live in today, Patel says, and it allows for more generation of energy that is decentralized, digitalized, decarbonized, and democratized — the four Ds as he says.

"When you consider our current grid system, it is a vestige of the industrial revolution — it's 140 years old. That business model is ripe for innovation," Patel says.

"We need to accelerate deployment of microgrid models," he continues. "I don't think we can afford to update our current grid system — it'll cost $2 trillion."

Most importantly, these microgrids need to be implemented in an equitable way, the founders say, and InnoGrid has its eyes on one Houston area in particular. The Innovation Corridor, which spans from the Texas Medical Center to Downtown Houston, would be the ideal region to deploy the technology.

"If you look at the innovation corridor, it forms the spine of the city. You have so many important municipal buildings, first-responding organizations, and a large amount of affordable housing in the area. There's critical resources here that we want to make sure the lights stay on in power disasters," Pettit says. "One of the things we believe at InnoGrid is that where you live shouldn't determine whether or not you survive a national weather event. We want to make sure we provide energy stability in the communities that need it most."

To make this dream into a reality, InnoGrid needs the right partnerships and support in the area — and the founders have made progress. InnoGrid recently participated in the Ion Smart and Resilient Cities Accelerator and has a relationship with Greentown Houston across the street.

Eventually, as Pettit says, InnoGrid wants to help lead Houston to becoming a hub for microgrid innovation.

"We're looking at other cities — like Chicago and Boston — and how they've deployed their microgrids and making sure we're bringing those best practices in Houston," Pettit says. "Eventually we want to be the leader in developing these microgrid best practices as the energy capital of the world."

Patel and Pettitt share more about InnoGrid and microgrid technology on the podcast. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”